Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019 - PubMed (original) (raw)

Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019

Elena A Goncharova et al. Am J Respir Crit Care Med. 2020.

No abstract available

1. Stearman RS, Bui QM, Speyer G, Handen A, Cornelius AR, Graham BB, et al. Systems analysis of the human pulmonary arterial hypertension lung transcriptome. Am J Respir Cell Mol Biol. 2019;60:637–649. - PMC - PubMed
1. Hamid R, Austin ED. End stage takes center stage in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2019;60:607–608. - PMC - PubMed
1. Weiss A, Neubauer MC, Yerabolu D, Kojonazarov B, Schlueter BC, Neubert L, et al. Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension. Nat Commun. 2019;10:2204. - PMC - PubMed
1. Ikeda KT, Hale PT, Pauciulo MW, Dasgupta N, Pastura PA, Le Cras TD, et al. Hypoxia-induced pulmonary hypertension in different mouse strains: relation to transcriptome. Am J Respir Cell Mol Biol. 2019;60:106–116. - PMC - PubMed
1. Marsh LM, Kwapiszewska G. Lessons from transcriptomics in hypoxia-induced pulmonary hypertension: does the mouse strain matter? Am J Respir Cell Mol Biol. 2019;60:13–15. - PubMed